Furosemide in the treatment of phosgene induced acute lung injury

Grainge, C., Smith, A.J., Jugg, B.J., Fairhall, S.J., Mann, T., Perrott, R., Jenner, J., Millar, T.M. and Rice, P. (2010) Furosemide in the treatment of phosgene induced acute lung injury. Journal of the Royal Army Medical Corps, 156, (4), 245-250. (PMID:21275359).


Full text not available from this repository.


Method: Using previously validated methods, 16 anaesthetised large white pigs were exposed to phosgene (target inhaled dose 0.3 mg kg(-1)), established on mechanical ventilation and randomised to treatment with either nebulised furosemide (4 ml of 10 mg x ml(-1) solution) or saline control. Treatments were given at 1, 3, 5, 7, 9, 12, 16 and 20 hours post phosgene exposure; the animals were monitored to 24 hours following phosgene exposure.

Results: Furosemide treatment had no effect on survival, and had a deleterious effect on PaO2: FiO2 ratio between 19 and 24 hours. All other measures investigated were unaffected by treatment.

Conclusion: Nebulised furosemide treatment following phosgene induced acute lung injury does not improve survival and worsens PaO2: FiO2 ratio. Nebulised furosemide should be avoided following phosgene exposure

Item Type: Article
ISSNs: 0035-8665 (print)
Related URLs:
Subjects: R Medicine > RC Internal medicine
R Medicine > RM Therapeutics. Pharmacology
Divisions : University Structure - Pre August 2011 > School of Medicine > Infection, Inflammation and Repair
ePrint ID: 178475
Accepted Date and Publication Date:
December 2010Published
Date Deposited: 24 Mar 2011 16:04
Last Modified: 31 Mar 2016 13:34
URI: http://eprints.soton.ac.uk/id/eprint/178475

Actions (login required)

View Item View Item